Forecasting Trends in Invasive Pneumococcal Disease among Elderly Adults in Quebec
Background. In Canada, the current recommendation is to offer PPV23 to adults ≥ 65 years. PCV13 is now licensed for adults. Methods. Invasive pneumococcal disease (IPD) cases in adults 65–74 years of age in the Quebec notifiable diseases registry were classified into five serotype categories. Poisso...
Saved in:
Main Authors: | Z. Zhou, G. Deceuninck, B. Lefebvre, P. De Wals |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2017/4347206 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pneumococcal Immunization Program in Montérégie, Québec: Feasibility Study
by: Maryse Guay, et al.
Published: (1999-01-01) -
Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992–2008)
by: Matthias Imöhl, et al.
Published: (2010-01-01) -
How Many Individuals with Asthma Need to Be Vaccinated to Prevent One Case of Invasive Pneumococcal Disease?
by: Julie M Okapuu, et al.
Published: (2014-01-01) -
Impact of invasive and noninvasive pneumococcal diseases on adult populations: risk factors and vaccination status
by: Hasip Kahraman, et al.
Published: (2025-02-01) -
Estimation of invasive pneumococcal disease dynamics parameters and the impact of conjugate vaccination in Australia
by: Karyn L. Sutton, et al.
Published: (2007-12-01)